With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
Will Garvin, shareholder in the firm's Life Sciences industry, authored "The Outlook on CBD: What Does 2020 Have in Store for the CBD Market?," published in BenefitsPro.
United States
Will Garvin, shareholder in the firm's Life Sciences
industry, authored "The Outlook on CBD: What Does 2020 Have in
Store for the CBD Market?," published in
BenefitsPro.
With a market estimated to grow more than 260% to a dizzying
$1.25 billion over the next four years, it appears that the demand
for cannabidiol, more commonly known as CBD, is expected to
continue to grow. All of this growth is still expected despite the
actions by the Food and Drug Administration (FDA).
The Outlook On CBD: What Does 2020 Have In Store For The CBD Market? - BenefitsPro
United States
Contributor
With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
